- Advertise
- Contact Us
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Practical Cardiology. All rights reserved.
Heart Failure
The Practical Cardiology(TM) Heart Failure clinical resource center is an information hub for the latest in heart failure and heart failure management. With a focus on heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF) this page features content including articles, videos, podcasts, and clinician-authored columns on FDA approvals, studies, guideline updates, and more.
Cardiology Month in Review: April 2022
April 23, 2022
Our cardiology month in review spotlights the most popular articles from the past month. This month's top articles include new heart failure guidelines, data from ACC.22, and more!
Initial Dips in eGFR Common with SGLT2 Inhibitors, Not Cause for Long-Term Concern
April 22, 2022
A post hoc analysis of DAPA-HF details the occurrence of eGFR declines within the first 14 days of starting therapy with dapagliflozin and the association of these declines with outcomes in the trial.
History of Infertility Linked to Increased Risk of Heart Failure in Women
April 19, 2022
An analysis of data from more than 35,000 women in the Women's Health Initiative indicates a history of infertility was independently associated with a 16% increase in risk of incident heart failure, with a 27% increase in risk of HFpEF, in postmenopausal women.
Obesity, Age at Menopause Play Integral Role in Heart Failure Risk Among Women
April 13, 2022
Data from an analysis of the ARIC study detail the increased risk of heart failure associated with obesity and increased waist circumference based on the age a woman enters menopause.
Assessing the Cost-Effectiveness of Sacubitril/Valsartan in Chronic Heart Failure Based on Ejection Fraction
April 06, 2022
Muthiah Vaduganathan, MD, MPH, discusses a study he took part in assessing the cost-effectiveness of sacubitril/valsartan among patients with an ejection fraction below normal.
Don't Miss a Beat: ACC.22 Recap of DIAMOND, SODIUM-HF, and PROMPT-HF
April 05, 2022
Don't Miss a Beat hosts Drs. Vaduganathan and Greene provide insight into the results of trials from ACC.22 late-breaking sessions they highlighted in the preview episode they recorded ahead of the American College of Cardiology's 71st Annual Scientific Session.
Patiromer Use Could Help Heart Failure Patients Stay on Optimized RAASi Therapy
April 04, 2022
Data from the DIAMOND trial suggests use of patiromer could help patients maintain optimized RAASi therapy, even if they were experiencing or had a history of hyperkalemia.
Sotagliflozin Reduces Stroke, MI, and CV Death, Regardless of CVD History
April 04, 2022
Deepak Bhatt, MD, MPH, breaks down data from the SCORED trial presented at ACC.22, which demonstrated sotagliflozin provided significant benefit in terms of reducing total MACE, total MI, and total stroke, regardless of whether a patient had a history of cardiovascular disease.
Q&A on SODIUM-HF and Impact of Salt Restriction, with Stephen Greene, MD
April 04, 2022
Stephen Greene, MD, discusses the results of SODIUM-HF, the effects of sodium restriction in different patient populations, and how he will apply the results to clinical practice.
Combination Therapy with SGLT2i and GLP-1 RA Well-Tolerated, Further Reduces MACE
April 03, 2022
Viet Le, PA-C, discusses a study he led examining the tolerability and clinical impact of initiating combination therapy with SGLT2 inhibitors and GLP-1 RAs compared to monotherapy with either agent within Intermountain Healthcare.